BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

RenovoRx and Imugene Join Forces for Oncolytic Virus Therapy Using TAMP Platform

Collaboration will explore trans-arterial delivery of Imugene's CF33 oncolytic virus utilizing RenovoRx's TAMP therapy platform TAMP enables localized, ...

July 25, 2023 | News

China's Mabwell Announces NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND

B7-H3 is a member of the B7 ligand family and is overexpressed in most cancer types but expressed at a low level in normal tissues. In malignant tissues, B...

July 24, 2023 | News

BioCity Initiates Phase 1 Trial with CDH3-Targeting ADC BC3195, First Patient Dosed

The study will assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of BC3195 in patients with locally advanced or metastatic solid ...

July 20, 2023 | News

SCG Cell Therapy Launches Cutting-edge Facility in Singapore for Cell Therapy Manufacturing & R&D

SCG Cell Therapy celebrates the opening of its new Cell Therapy Manufacturing Facility and R&D Centre, launching a new first-of-its-kind automatic ce...

July 20, 2023 | News

Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow

Summary Total revenue up 21% quarter-on-quarter to $120.7M driven by global product sales Positive operating cash flow ($10.8M, an improvemen...

July 20, 2023 | News

Merck and Telix Continue Collaboration for Targeted Radiation Therapy Studies.

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Com...

July 19, 2023 | News

Thermo Fisher Scientific Introduces New Reproductive Health Assays to Accelerate Fertility Research

o extend the benefits of genomic testing research for reproductive health labs, Thermo Fisher Scientific today launched two new next-generation sequencing-...

July 18, 2023 | News

Antengene Administers First Patient in US Clinical Study of ATG-017 for Advanced Solid Tumors with Nivolumab Combination

- ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...

July 18, 2023 | News

WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturing Line at Wuxi City Site

The new HP injectable manufacturing line meets Occupational Exposure Limits (OEL) as low as 10 ng/m3 and utilizes fully enclosed isolation systems and...

July 18, 2023 | News

Lonza Launches TheraPRO® CHO Media System

Lonza’s new cell culture media system is designed to optimize the production of therapeutic monoclonal antibodies The two-part production system i...

July 17, 2023 | News

GeneQuantum and InxMed Partner for Innovative ADC Drug Research

According to the agreement, GeneQuantum will provide InxMed with its independently developed, globally leading technologies in site-specific glycan conjuga...

July 17, 2023 | News

CRISPR Gene Editing Opens New Treatment Avenues for Alzheimer's

Two new CRISPR-based strategies offer hope for next-generation Alzheimer's treatments. One seeks to dampen the impact of the most common Alzheimer's ris...

July 17, 2023 | News

OneStudyTeam Expands Global Research Reach to 4,000 Sites Across EMEA, LATAM, and Asia-Pacific

OneStudyTeam, the maker of the patient enrollment management platform StudyTeam, today announced that StudyTeam is now being used by more than 4,000 clinic...

July 17, 2023 | News

Raya Therapeutic announces early-stage R&D collaboration with argenx

"We are delighted to be entering this early-stage R&D collaboration with argenx. argenx is one of the industry's most exciting companies, and their bel...

July 13, 2023 | News

Stay Connected